If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
2
Followers on Owler
ABAC develops antimicrobial agents for the treatment of bacterial infections...
Read more
Overview
Competitors
Funding
News & Insights
ABAC develops antimicrobial agents for the treatment of bacterial infections...
Read more
CEO
Albert Palomer
CEO Approval Rating
76/100
Weigh In
2014
Barcelona
Barcelona
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://www.abactherapeutics.com
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$19.8M
News
Latest News
Sep 08, 2022
Business Wire India
Press Release: Abactherapeutics : Scientists from Spain and India Lead an International Project to Develop New Antibiotics Against Gram-Negative Bacteria
Feb 15, 2018
BioSpace
ABAC: ABAC Therapeutics Announces €16M Series A to Develop Therapeutic Solutions to Fight Antibiotic-Re...
Feb 15, 2018
The Pharma Letter
ABAC: ABAC Therapeutics raises 16 million euros from investors including Debiopharm
Feb 15, 2018
Manufacturing Chemist
ABAC: Debiopharm continues fight against antibiotic resistance
Follow and Get Alerts
Abactherapeutics Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 16 + competitors
Trending Companies